The hope is that more biosimilars will lead to more access and more affordable medications, but biosimilar uptake is lagging. Here’s why and how FDA hopes to fix it.
Ryan's proposals for radical changes in Medicare and Medicaid are at the center of the presidential campaign.
Employers weighing coverage options will continue providing healthcare benefits.
The GOP is looking to gain control of the White House and Congress to restructure healthcare.
Policymakers examine Medicare reform proposals in an attempt to control spending.
Efforts to reduce outlays are generating initiatives to better manage the care for some 10 million dual eligibles.
Medicare Part D plans apply a range of tools to control costs and provide quality care.
Everyone has their take on the Supreme Court ruling, but it's time for the industry to roll up its sleeves and get back to work.
Medicare data could give payers information on rising provider costs.
Congress wants to get serious about fixing the Medicare formula for reimbursing physicians, an initiative that would affect healthcare rates and expenditures more broadly.